Innovative Pharmaceutical Biotech's total assets for Q4 2024 were HK$1.09B, a decrease of -21.30% from the previous quarter. HK:0399 total liabilities were HK$1.06B for the fiscal quarter, a 16.77% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.